Androstenone derivative
US5846976A · kind A · utility
10Cited by
26References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 1996 |
| Grant date | Dec 8, 1998 |
| Priority date | — |
| Expiry date | Aug 22, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to the compound of formula (I), ##STR1## also known as 17.beta.-N-(2,5-bis(Trifluoromethyl))phenylcarbamoyl-4-aza-5.alpha.-andros t-1-en-3-one, solvates thereof, its preparation, intermediates used in its preparation, pharmaceutical formulations thereof and its use in the treatment of androgen responsive and mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.